Quick Answer
Roche is a Swiss healthcare company that reported CHF 61.5 billion in 2025 group sales, including CHF 47.7 billion from Pharmaceuticals and CHF 13.8 billion from Diagnostics.
Why Roche Matters
Roche combines medicines and diagnostics at global scale. That makes it important in oncology and precision medicine, where identifying the right patient can be as important as the drug itself.
Financial Snapshot
In 2025, Roche reported CHF 61.5 billion in group sales, CHF 21.8 billion in core operating profit, and CHF 12.2 billion in R&D core investments.
Strategic Question
The key question is whether Roche can use diagnostics, oncology data, and new drug launches to offset biosimilar erosion and pricing pressure on older medicines.
